butyloxycarbonyl-phenylalanyl-leucyl-phenylalanyl-leucyl-phenylalanine has been researched along with lysophosphatidylcholines in 1 studies
| Studies (butyloxycarbonyl-phenylalanyl-leucyl-phenylalanyl-leucyl-phenylalanine) | Trials (butyloxycarbonyl-phenylalanyl-leucyl-phenylalanyl-leucyl-phenylalanine) | Recent Studies (post-2010) (butyloxycarbonyl-phenylalanyl-leucyl-phenylalanyl-leucyl-phenylalanine) | Studies (lysophosphatidylcholines) | Trials (lysophosphatidylcholines) | Recent Studies (post-2010) (lysophosphatidylcholines) |
|---|---|---|---|---|---|
| 31 | 1 | 17 | 5,058 | 39 | 976 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hung, ND; Kim, MR; Sok, DE | 1 |
1 other study(ies) available for butyloxycarbonyl-phenylalanyl-leucyl-phenylalanyl-leucyl-phenylalanine and lysophosphatidylcholines
| Article | Year |
|---|---|
Mechanisms for anti-inflammatory effects of 1-[15(S)-hydroxyeicosapentaenoyl] lysophosphatidylcholine, administered intraperitoneally, in zymosan A-induced peritonitis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cytokines; Eicosapentaenoic Acid; In Vitro Techniques; Inflammation Mediators; Injections, Intraperitoneal; Leukocytes; Leukotriene B4; Leukotriene C4; Lysophosphatidylcholines; Male; Mice; Mice, Inbred ICR; Oligopeptides; Oxidation-Reduction; Peritonitis; Structure-Activity Relationship; Zymosan | 2011 |